Clinical Trials Directory

Trials / Completed

CompletedNCT00621712

Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties

Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties: Efficacy and Effect of Intensive Catheter and Exit Site Care Education

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Vantive Health LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study investigates the efficacy of a catheter with antibacterial surface coating in preventing central venous catheter related infection and the effect of an intensive hygiene and catheter care education of the nursing staff on preventing central venous catheter-related infection.

Detailed description

The risk of catheter-related bloodstream infection depends on catheter type, method and site of insertion, aseptic technique and number of manipulations. To address this problem, efforts have focused on engineering biomaterials and surfaces with antibacterial properties to prevent bacteria adhesion and biofilm formation. In view of the necessity to reduce catheter-related bloodstream infections and of the inadequacy of currently available antimicrobially coated devices, a new antimicrobial catheter surface was developed. Among other factors, the mode and quality of catheter handling and care of exit site is an important aspect with respect to catheter-related infections. The clinical study aims at providing data on antimicrobial efficiency of the 2 types of CE certified double lumen catheters and a supposed additional preventive effect of intense hygiene training on catheter-related infections.

Conditions

Interventions

TypeNameDescription
DEVICEGamCath® central venous catheterchoice of catheter type
DEVICEGamCath Dolphin® Protect central venous catheterchoice of catheter type

Timeline

Start date
2007-10-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2008-02-22
Last updated
2025-03-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00621712. Inclusion in this directory is not an endorsement.